GlobeNewswire by notified

Norsk Hydro: Status share buyback program

Share

Please see below information about transactions made under the share buyback program for Norsk Hydro ASA.

Announcement date of the share buyback program: September 22, 2023
End date of the share buyback program: February 29, 2024

Overview of transactions:

Date Aggregate daily volume (no. of shares) Average price (NOK) Total transaction value (NOK)
25.10.23 449 929  60.41  27 181 111
26.10.23 200 000  61.33  12 266 580
27.10.23 260 000  60.40  15 702 830
30.10.23 260 000  61.94  16 104 634
31.10.23 211 363  63.57  13 435 987
Previous transactions 5 044 575
Accumulated to date 6 425 867  61.86  397 516 662


Prior to the share buyback program Norsk Hydro ASA owned a total of 15 096 878 own shares. Following the above listed transactions, Norsk Hydro ASA owns a total of 21 522 745 shares, corresponding to 1.05% of Norsk Hydro ASA's share capital.

Attachment: An overview of all the completed transactions under the program for the dates specified above is attached to this notification and available on www.newsweb.no.

This is information that Norsk Hydro ASA is obliged to make public pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.


Investor contact:

Martine Rambøl Hagen
Head of Investor Relations
+47 91708918
Martine.Rambol.Hagen@hydro.com 

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Correction: Announcement of drawings (CK95) - Nykredit Realkredit A/S28.11.2023 15:01:23 CET | Press release

To Nasdaq Copenhagen Announcement of drawings (CK95) Pursuant to s 24 Danish Capital Markets Act, Nykredit Realkredit A/S hereby publishes drawings data as at 24 November 2023. Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on https://www.nykredit.com/en-gb/investor-relations/. For further information about data format and contents, please refer to the Nasdaq website. Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21. Yours sincerely Nykredit Realkredit A/S Attachments Announcement of drawings Nykredit Realkredit A_S - 28-11-2023kfdata

Korrektion: Udtrækningsmeddelelse (CK95) - Nykredit Realkredit A/S28.11.2023 15:01:23 CET | pressemeddelelse

Til Nasdaq Copenhagen Udtrækningsmeddelelse (CK95) I medfør af kapitalmarkedsloven § 24 offentliggør Nykredit Realkredit A/S hermed meddelelse om udtrækninger pr. den 24. november 2023. Oplysningerne vil endvidere på sædvanlig måde blive formidlet via Nasdaq Copenhagen. Oplysningerne findes også i excel-format i Nykredits obligationsdatabase på https://www.nykredit.com/en-gb/investor-relations/. For yderligere informationer om dataformat og indhold henvises til Nasdaqs hjemmeside. Spørgsmål kan rettes til head of investor relations Morten Bækmand Nielsen på tlf. 44 55 15 21. Med venlig hilsen Nykredit Realkredit A/S Vedhæftede filer Udtrækningsmeddelelse Nykredit Realkredit A_S - 28-11-2023kfdata

Philips launches ultra lightweight and flexible MR Smart Fit coils to improve radiology productivity and diagnostic confidence at #RSNA2328.11.2023 15:00:00 CET | Press release

November 28, 2023 Amsterdam, the Netherlands and Chicago, USA – RoyalPhilips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today launched three new fit for purpose MR Smart Fit coils at #RSNA23. RF coils are an essential part of every MRI scan. The new ultra-light weight coils provide exceptional flexibility, significant reduction in patient setup time and optimization with Philips’ SmartSpeed AI solution, which allows for better image quality resolution and improved diagnostic confidence for healthcare providers. “Our new Smart Fit coils are an integral part of our patient-centric workflows in MR, with a focus on raising productivity and simplifying workflow,” said Ruud Zwerink, General Manager Magnetic Resonance at Philips. “They combine with our advanced AI-powered software that reduces scanning time and dramatically cuts the number of steps needed to complete an exam. These newly designed coils will help to speed up MR exam process, improving both efficiency and the

Ledende medarbejders transaktioner28.11.2023 14:58:15 CET | pressemeddelelse

Selskabsmeddelelse Nr. 7/2023 København, 28. november 2023 Ledende medarbejders transaktioner Bestyrelsen i Conferize A/S er i dag blevet bekendt med, at 7 investorer har købt 40,26 pct. af selskabets eksisterende aktier fra selskabets 2 hovedaktionærer til en samlet pris på ca. 0,8 mio. kr. – svarende til en pris på 0,01 kr. pr. aktie. Direktør Nicolai Bille Krogh har solgt aktier i Conferize A/S. NAVN:7DREAMS ApSÅRSAG:Nærtstående til Nicolai Bille Krogh, DirektørUDSTEDER:Conferize A/SFONDSKODE:DK0060816148BETEGNELSE:AktierTRANSAKTION:SalgHANDELSDATO:28.11.2023MARKED:Nasdaq First North Growth MarketANTAL STK:40.078.446SALGSSUM DKK:400.784,46 Herudover har Rothausen Development 2016 ApS ejet og kontrolleret af direktør i Suubz ApS, datterselskab i Conferize A/S, solgt aktier i Conferize A/S NAVN:Rothausen Development 2016 ApSÅRSAG:Nærtstående til Claus Andersen, Direktør i datterselskab Suubz ApSUDSTEDER:Conferize A/SFONDSKODE:DK0060816148BETEGNELSE:AktierTRANSAKTION:SalgHANDELSDATO:28

2024 Financial Calendar28.11.2023 14:56:32 CET | Press release

28 November 2023 News Release Pharma Equity Group 2024 Financial Calendar ​March 4Deadline for shareholder proposals - Annual General meeting​ ​March 20 ​Annual Report 2023​ April 16Annual General Meeting​ May 16Interim Report – for the three-month period ended March 31, 2024​ August 16Interim Report – for the six-month period ended June 30, 2024​ November 15Interim Report – for the nine-month period ended September 30, 2024 ​ Contact person – Investor Relations On the Company’s website www.pharmaequitygroup.com further information and all published announcements can be found. Inquiries regarding relations with investors and the stock market can be directed to: Thomas Kaas Selsø, CEO, Phone: +45 4022 2114 E-mail: investor@pharmaequitygroup.com. About Pharma Equity Group A/S Pharma Equity Group, a listed company on the Nasdaq Copenhagen stock exchange, is fully dedicated to advancing the medical projects of its subsidiary, Reponex Pharmaceuticals A/S. With an unwavering focus on healthc